QuantaSing Group Limited American Depositary Shares (QSG) had the highest return between January 8, 2024 and January 30, 2024 by a small-cap US stock, returning 117.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
QuantaSing Group Limited American Depositary Shares (QSG) | 1/8/2024 - 1/30/2024 | 117.29% |
Clene (CLNNW) | 1/8/2024 - 1/30/2024 | 104.08% |
Edgewise Therapeutics (EWTX) | 1/8/2024 - 1/30/2024 | 72.47% |
Real Brokerage (REAX) | 1/8/2024 - 1/30/2024 | 66.67% |
Immunome (IMNM) | 1/8/2024 - 1/30/2024 | 63% |
ADC Therapeutics (ADCT) | 1/8/2024 - 1/30/2024 | 58.13% |
Arcutis Biotherapeutics (ARQT) | 1/8/2024 - 1/30/2024 | 56.53% |
Dianthus Therapeutics (DNTH) | 1/8/2024 - 1/30/2024 | 51.44% |
Praxis Precision Medicines (PRAX) | 1/8/2024 - 1/30/2024 | 50.54% |
Mereo BioPharma Group PLC ADR (MREO) | 1/8/2024 - 1/30/2024 | 50% |
Oric Pharmaceuticals (ORIC) | 1/8/2024 - 1/30/2024 | 46.18% |
GH Research (GHRS) | 1/8/2024 - 1/30/2024 | 44.84% |
Intuitive Machines (LUNR) | 1/8/2024 - 1/30/2024 | 44.68% |
Cullinan Oncology LLC (CGEM) | 1/8/2024 - 1/30/2024 | 43.21% |
Innodata (INOD) | 1/8/2024 - 1/30/2024 | 43.14% |
Net Lease Office Properties (NLOP) | 1/8/2024 - 1/30/2024 | 42.69% |
Establishment Labs (ESTA) | 1/8/2024 - 1/30/2024 | 41.82% |
Tourmaline Bio (TRML) | 1/8/2024 - 1/30/2024 | 41.09% |
Kura Oncology (KURA) | 1/8/2024 - 1/30/2024 | 40.78% |
Tarsus Pharmaceuticals (TARS) | 1/8/2024 - 1/30/2024 | 40.11% |
Verastem (VSTM) | 1/8/2024 - 1/30/2024 | 38.58% |
POET Technologies (POET) | 1/8/2024 - 1/30/2024 | 38.3% |
Ardelyx (ARDX) | 1/8/2024 - 1/30/2024 | 37.54% |
Neuropace (NPCE) | 1/8/2024 - 1/30/2024 | 35.14% |
SEALSQ (LAES) | 1/8/2024 - 1/30/2024 | 34.81% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
